Previous close | 7.94 |
Open | 7.88 |
Bid | 7.71 x 100 |
Ask | 7.77 x 100 |
Day's range | 7.72 - 7.96 |
52-week range | 5.12 - 17.57 |
Volume | |
Avg. volume | 1,256,650 |
Market cap | 590.761M |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Travere Therapeutics, Inc. ( NASDAQ:TVTX ) shareholders should be happy to see the share price up 21% in the last...
With the business potentially at an important milestone, we thought we'd take a closer look at Travere Therapeutics...
Discover how Travere Therapeutics Inc (TVTX) achieved a robust revenue increase and navigated regulatory landscapes in the first quarter of 2024.